• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对小鼠B细胞淋巴瘤的独特型疫苗接种。抗肿瘤免疫充分表达的体液和细胞需求。

Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.

作者信息

Campbell M J, Esserman L, Byars N E, Allison A C, Levy R

机构信息

Stanford University School of Medicine, Department of Medicine, CA 94306.

出版信息

J Immunol. 1990 Aug 1;145(3):1029-36.

PMID:2373859
Abstract

The roles of humoral and cellular antitumor immune responses induced by immunization with tumor-derived idiotypic IgM were studied in a syngeneic, transplantable B cell lymphoma (38C13) of C3H mice. Id vaccination with keyhole limpet hemocyanin-conjugated Id induced protection against a subsequent lethal tumor challenge. Such immunizations elicited anti-idiotypic antibodies that were cytotoxic in in vitro antibody-dependent cellular cytotoxicity assays as well as in vivo passive transfer experiments. L3T4+ T cells, which proliferated in vitro in response to the specific Id protein, were also induced. However, cells mediating direct cytotoxicity, either in vitro or in vivo, were not observed in the lymph nodes, spleens, or peritoneal cavity of immune mice or at the site of tumor regression as demonstrated by using a tumor sponge implantation model. In addition, in vitro sensitization of immune lymphocytes against 38C13 tumor cells failed to induce cytotoxicity. Immunization with lipid conjugated Id also elicited a T cell proliferative response but failed to induce anti-idiotypic antibodies and did not confer resistance to tumor growth. These results suggest that anti-idiotypic antibodies play the major role in the destruction of 38C13 tumor cells. However, in vivo depletion of L3T4+ or Lyt-2+ cells from 38C-Id-keyhole limpet hemocyanin-immunized mice resulted in diminished protection against a tumor challenge. Thus, although humoral responses appear to play the predominant part in tumor destruction, cellular responses are also required for the full expression of antitumor immunity in this system.

摘要

在C3H小鼠的同基因、可移植B细胞淋巴瘤(38C13)中,研究了用肿瘤衍生的独特型IgM免疫诱导的体液和细胞抗肿瘤免疫反应的作用。用钥孔戚血蓝蛋白偶联的独特型进行独特型疫苗接种可诱导对随后致死性肿瘤攻击的保护作用。这种免疫接种引发了抗独特型抗体,这些抗体在体外抗体依赖性细胞毒性试验以及体内被动转移实验中具有细胞毒性。还诱导了L3T4 + T细胞,它们在体外对特异性独特型蛋白产生增殖反应。然而,通过肿瘤海绵植入模型证明,在免疫小鼠的淋巴结、脾脏或腹腔中,或在肿瘤消退部位,均未观察到在体外或体内介导直接细胞毒性的细胞。此外,免疫淋巴细胞对38C13肿瘤细胞的体外致敏未能诱导细胞毒性。用脂质偶联的独特型进行免疫接种也引发了T细胞增殖反应,但未能诱导抗独特型抗体,也未赋予对肿瘤生长的抗性。这些结果表明,抗独特型抗体在38C13肿瘤细胞的破坏中起主要作用。然而,从38C - 独特型 - 钥孔戚血蓝蛋白免疫的小鼠体内清除L3T4 +或Lyt - 2 +细胞会导致对肿瘤攻击的保护作用减弱。因此,尽管体液反应似乎在肿瘤破坏中起主要作用,但在该系统中,细胞反应对于抗肿瘤免疫的充分表达也是必需的。

相似文献

1
Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.针对小鼠B细胞淋巴瘤的独特型疫苗接种。抗肿瘤免疫充分表达的体液和细胞需求。
J Immunol. 1990 Aug 1;145(3):1029-36.
2
Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.针对小鼠B细胞淋巴瘤的独特型疫苗接种。肿瘤衍生免疫球蛋白M及其分子亚基引发的体液和细胞反应。
J Immunol. 1987 Oct 15;139(8):2825-33.
3
Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.针对小鼠B细胞淋巴瘤的独特型疫苗接种。游离独特型蛋白对肿瘤免疫的抑制作用。
J Immunol. 1987 Feb 15;138(4):1289-96.
4
Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.参与抑制小鼠B细胞淋巴瘤BCL1的抗独特型机制。
J Immunol. 1987 Jan 15;138(2):628-34.
5
Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.B细胞淋巴瘤骨髓移植后独特型疫苗接种:小鼠模型的初步研究
Cancer Detect Prev. 1991;15(4):323-5.
6
DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.针对小鼠B细胞淋巴瘤独特型的DNA疫苗接种:肿瘤保护机制
J Immunol. 1999 Apr 15;162(8):4790-5.
7
Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.一种B细胞白血病的生长抑制:提示抗独特型免疫反应参与保护性肿瘤免疫的证据。
J Immunol. 1986 Aug 15;137(4):1371-5.
8
Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.鼠源B细胞淋巴瘤经抗独特型单克隆抗体治疗后出现的独特型变体。
J Immunol. 1989 Jan 1;142(1):343-51.
9
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.针对小鼠B细胞淋巴瘤的独特型疫苗接种策略:负载独特型以及双特异性独特型x抗II类抗体的树突状细胞可预防肿瘤生长。
Cytokines Mol Ther. 1996 Dec;2(4):231-8.
10
Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.鼠源B细胞淋巴瘤的双特异性抗独特型/抗CD3抗体疗法。
J Immunol. 1991 Dec 1;147(11):4035-44.

引用本文的文献

1
B Cells With Complementary B Cell Receptors Can Kill Each Other.具有互补性B细胞受体的B细胞会相互杀伤。
Eur J Immunol. 2025 Jan;55(1):e202350890. doi: 10.1002/eji.202350890. Epub 2024 Nov 9.
2
Recent Progress in Dendritic Cell-Based Cancer Immunotherapy.基于树突状细胞的癌症免疫疗法的最新进展。
Cancers (Basel). 2021 May 20;13(10):2495. doi: 10.3390/cancers13102495.
3
Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.免疫原性独特型:应对诱导针对免疫球蛋白可变区的强治疗性免疫应答的挑战。
Front Oncol. 2012 Nov 9;2:159. doi: 10.3389/fonc.2012.00159. eCollection 2012.
4
Novel immunotherapies.新型免疫疗法。
Cancer J. 2009 Nov-Dec;15(6):502-10. doi: 10.1097/PPO.0b013e3181c51f0d.
5
Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures.淋巴瘤的独特型疫苗:原理验证及临床试验失败情况
Nat Rev Cancer. 2009 Sep;9(9):675-81. doi: 10.1038/nrc2717.
6
Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines.马来酰亚胺偶联显著增强了人源和鼠源独特型-KLH疫苗的免疫原性。
Mol Immunol. 2009 Jan;46(3):448-56. doi: 10.1016/j.molimm.2008.10.020. Epub 2008 Nov 28.
7
Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo.负载凋亡抗体包被肿瘤细胞的树突状细胞在体内提供针对B细胞淋巴瘤的保护性免疫。
Blood. 2008 Feb 1;111(3):1504-11. doi: 10.1182/blood-2007-03-080507. Epub 2007 Nov 9.
8
Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.李斯特菌溶血素O是一种用于淋巴瘤免疫球蛋白独特型的改良蛋白载体,可提供针对38C13淋巴瘤的全身保护。
Cancer Immunol Immunother. 2008 Apr;57(4):493-505. doi: 10.1007/s00262-007-0388-y. Epub 2007 Sep 18.
9
CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors.表达CCR4的T细胞肿瘤可通过将毒素传递至趋化因子受体而得到特异性控制。
J Immunol. 2007 Aug 1;179(3):1996-2004. doi: 10.4049/jimmunol.179.3.1996.
10
Clinical utilization of chemokines to combat cancer: the double-edged sword.趋化因子在抗癌治疗中的临床应用:一把双刃剑。
Expert Rev Vaccines. 2007 Apr;6(2):267-83. doi: 10.1586/14760584.6.2.267.